Ann OCallaghan
Overview
Explore the profile of Ann OCallaghan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joharatnam-Hogan N, Hatem D, Cafferty F, Petrucci G, Cameron D, Ring A, et al.
Br J Cancer
. 2023 Jul;
129(4):706-720.
PMID: 37420000
Background: Pre-clinical models demonstrate that platelet activation is involved in the spread of malignancy. Ongoing clinical trials are assessing whether aspirin, which inhibits platelet activation, can prevent or delay metastases....
2.
Wijaya R, Johnson M, Campbell N, Stuart B, Kelly A, Tipler N, et al.
Lancet
. 2023 Jul;
402(10396):99-102.
PMID: 37393922
No abstract available.
3.
Williams C, Elliott F, Sapanara N, Aghaei F, Zhang L, Muranyi A, et al.
Clin Cancer Res
. 2023 Jun;
29(20):4153-4165.
PMID: 37363997
Purpose: High tumor production of the EGFR ligands, amphiregulin (AREG) and epiregulin (EREG), predicted benefit from anti-EGFR therapy for metastatic colorectal cancer (mCRC) in a retrospective analysis of clinical trial...
4.
Lim S, Stuart B, Joseph-Pietras D, Johnson M, Campbell N, Kelly A, et al.
Nat Cancer
. 2022 Mar;
3(5):552-564.
PMID: 35332334
Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes due to compromised immune responses, but the insights of these studies have been compromised due to intrinsic limitations...
5.
Lim S, Campbell N, Johnson M, Joseph-Pietras D, Collins G, OCallaghan A, et al.
Lancet Haematol
. 2021 Jul;
8(8):e542-e544.
PMID: 34224667
No abstract available.
6.
McCann K, Mander A, Cazaly A, Chudley L, Stasakova J, Thirdborough S, et al.
Clin Cancer Res
. 2016 Apr;
22(19):4827-4836.
PMID: 27091407
Purpose: We have clinically evaluated a DNA fusion vaccine to target the HLA-A*0201-binding peptide CAP-1 from carcinoembryonic antigen (CEA) linked to an immunostimulatory domain (DOM) from fragment C of tetanus...
7.
Seymour M, Brown S, Middleton G, Maughan T, Richman S, Gwyther S, et al.
Lancet Oncol
. 2013 Jun;
14(8):749-59.
PMID: 23725851
Background: Therapeutic antibodies targeting EGFR have activity in advanced colorectal cancer, but results from clinical trials are inconsistent and the population in which most benefit is derived is uncertain. Our...